E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 7/2/2008 in the Prospect News PIPE Daily.

New Issue: Neovasc completes C$8.3 million private placement of shares

By Devika Patel

Knoxville, Tenn., July 2 - Neovasc Inc. said it took in C$8.3 million in a private placement of stock.

The company sold about 3 million common shares and warrants to several new investors, including The Frost Group, led by Phillip Frost, and Peregrine Ventures. A number of existing investors, including Gagnon Securities and Neovasc chairman Paul Geyer, also participated in the financing.

Neovasc, formerly Medical Ventures Corp., is a Richmond, B.C.-based medical device company.

Issuer:Neovasc Inc.
Issue:Common shares
Amount:C$8.3 million
Shares:3 million (approximate)
Warrants:3 million (approximate)
Investors:The Frost Group, led by Phillip Frost, Peregrine Ventures, Gagnon Securities, Paul Geyer
Settlement date:July 2
Stock symbol:TSX Ventures: MEV
Stock price:C$2.30 at close July 1

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.